You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation for DABIGATRAN ETEXILATE MESYLATE


✉ Email this page to a colleague

« Back to Dashboard


US Court Litigation for DABIGATRAN ETEXILATE MESYLATE

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,087,380 Boehringer Ingelheim Pharma GmbH & Co. KG v. Teva Pharmaceuticals USA Inc. ⤷  Sign Up 2015-01-15 2015-04-22 35:271 Patent Infringement District Court, D. Delaware None ⤷  Sign Up
6,087,380 ⤷  Sign Up ⤷  Sign Up 2015-04-29 2016-07-06 05:0706 Judicial Review of Agency Actions District Court, District of Columbia ⤷  Sign Up
6,087,380 ⤷  Sign Up ⤷  Sign Up 2014-12-14 2018-01-25 35:145 Patent Infringement District Court, D. New Jersey None ⤷  Sign Up
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.